1. Home
  2. SNGX vs LUCY Comparison

SNGX vs LUCY Comparison

Compare SNGX & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.39

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

HOLD

Current Price

$0.76

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
LUCY
Founded
1987
2017
Country
United States
United States
Employees
N/A
13
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.7M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SNGX
LUCY
Price
$0.39
$0.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
903.1K
50.1K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
$175.92
Revenue Next Year
N/A
$205.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.66
52 Week High
$6.23
$2.39

Technical Indicators

Market Signals
Indicator
SNGX
LUCY
Relative Strength Index (RSI) 39.82 34.47
Support Level $0.37 $0.66
Resistance Level $0.41 $1.17
Average True Range (ATR) 0.02 0.06
MACD 0.01 0.00
Stochastic Oscillator 21.25 38.46

Price Performance

Historical Comparison
SNGX
LUCY

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.

Share on Social Networks: